Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company developing first-in-class therapies for cancer ...
Servier today announced longer-term data from the Phase 3 INDIGO trial evaluating VORANIGO® (vorasidenib) versus placebo in patients with Grade 2 mutant isocitrate dehydrogenase 1 or 2 (mIDH1/2) ...
A new review published in the Chinese Medical Journal provides one of the most detailed examinations to date of how ...
Discover how chromium, magnesium, zinc, and other micronutrients influence insulin sensitivity and glucose metabolism—key factors in preventing and managing Type 2 diabetes.
A inhibitors does not trigger MACEs when compared with TNF- α inhibitors in the 6 months following treatment initiation.
Inflammatory arthritis resulting from immune checkpoint inhibitor use is immunologically unique and likely driven by T cells ...
Merck and Eisai Provide Update on Phase 3 LEAP-012 Trial in Unresectable, Non-Metastatic Hepatocellular Carcinoma ...
Verywell Health on MSN
What Happens to Your Body When You Drink Pomegranate Juice Regularly?
Medically reviewed by Allison Herries, RDN Drinking pomegranate juice may offer health benefits, such as improved heart ...
Travere Therapeutics, Inc. today reported its third quarter 2025 financial results and provided a corporate update. "We delivered outstanding commercial performance in the third quarter, reflecting ...
Objective To investigate the association between peripheral disease activity and pre-eclampsia, gestational hypertension, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback